5-Aminolevulinic Acid as a Novel Therapeutic for Inflammatory Bowel Disease
نویسندگان
چکیده
منابع مشابه
Diet as a Therapeutic Option for Adult Inflammatory Bowel Disease.
There are many mechanisms to explain how food may drive and ameliorate inflammation. Although there are no consistent macronutrient associations inflammatory bowel disease (IBD) development, many exclusion diets have been described: IgG-4 guided exclusion diet; semivegetarian diet; low-fat, fiber-limited exclusion diet; Paleolithic diet; Maker's diet; vegan diet; Life without Bread diet; exclus...
متن کاملPDE4 Inhibition and Inflammatory Bowel Disease: A Novel Therapeutic Avenue
BACKGROUND In the last few decades, a better knowledge of the inflammatory pathways involved in the pathogenesis of Inflammatory Bowel Disease (IBD) has promoted biological therapy as an important tool to treat IBD patients. However, in spite of a wider spectrum of biological drugs, a significant proportion of patients is unaffected by or lose their response to these compounds, along with incre...
متن کاملStem cells as potential therapeutic targets for inflammatory bowel disease.
The incidence and prevalence of Crohn's disease and ulcerative colitis, the two major forms of inflammatory bowel disease (IBD), are rising. According to some estimates >1 million new cases of IBD arise in the United States annually. The conventional therapies available for IBD range from anti-inflammatory drugs to immunosuppressive agents, but these therapies generally fail to achieve satisfac...
متن کاملReview article: helminths as therapeutic agents for inflammatory bowel disease.
Over the last decade major advances have been made in our understanding of the mechanisms and mediators of inflammation that hold the promise of the development of new therapies for inflammatory disease. While much is to be gleaned from the application of new technologies, assessment of the age-old host-parasite relationship may also provide insights on how to counter pathological inflammatory ...
متن کاملButyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease.
Inflammatory bowel disease (IBD), of which Crohn’s disease (CD) and ulcerative colitis (UC) are the most common manifestations, is characterized by chronic inflammation of the lining of the gastrointestinal tract, which causes severe watery and bloody diarrhoea, and abdominal pain. IBD is often debilitating and is characterized by onset at a young age and extra-intestinal manifestations. Wherea...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Biomedicines
سال: 2021
ISSN: 2227-9059
DOI: 10.3390/biomedicines9050578